DMedical announced today that it raised more than $100 million (AU$150 million) through a new institutional placement.

Expanded eligibility for advanced stroke therapies and new recommendations for diagnosing and treating stroke in children and ...

Expanded eligibility for advanced stroke therapies and new recommendations for diagnosing and treating stroke in children and adults are among the major updates in the new 2026 Guideline for the Early ...

DMedical, the leader in software-based respiratory imaging technology, today announced US$100+ million (AU$150 million) in new institutional placement. The investment will primarily be leveraged to ...

FRIDAY, Jan. 23, 2026 (HealthDay News) — Brain tumors are abnormal growths of cells in or around the brain. They can be ...

DMedical Limited (ASX:4DX), a global leader in respiratory imaging technology, has announced an expanded partnership with the ...

Postoperative recurrence (POR) is a major challenge in the long-term management of Crohn’s disease (CD), affecting up to 70% ...

Ischemic stroke is a leading cause of death and disability in the Western world. At present, intravenous administration of tissue plasminogen activator within 3 h of symptom onset is the only proven ...